Clinical Trials Logo

Filter by:
NCT ID: NCT01511913 Completed - Clinical trials for Advanced Cutaneous Melanoma

A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma

IMAGE
Start date: June 3, 2012
Phase:
Study type: Observational

The purpose of this study is to examine the safety of Ipilimumab and patterns of use in the treatment of unresectable or metastatic melanoma in the post-approval setting

NCT ID: NCT01511770 Completed - Healthy Clinical Trials

Bioavailability Study of Fluconazole Tablets 200 mg Under Fasting Conditions

Start date: August 2002
Phase: Phase 1
Study type: Interventional

The objective of this study was an open-label, randomized, 2-way crossover to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Pfizer (Diflucan®) 200 mg fluconazole tablets under fasting conditions.

NCT ID: NCT01511757 Completed - Healthy Clinical Trials

Bioavailability Study of Fluconazole Tablets 200 mg Under Fed Conditions

Start date: June 2002
Phase: Phase 1
Study type: Interventional

The objective of this study was an open-label, randomized, 2-way crossover to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Pfizer (Diflucan®) 200 mg fluconazole tablets under fed conditions.

NCT ID: NCT01511731 Completed - Healthy Clinical Trials

Bioavailability Study of Famotidine Tablets 40 mg Under Fasting Conditions

Start date: October 1998
Phase: Phase 1
Study type: Interventional

The objective of this study was to compare the single-dose relative bioavailability of Reddy Cheminor and Merck &Co, pepcid 40 mg famotidine tablets under fasting conditions.

NCT ID: NCT01511653 Completed - Rectal Cancer Clinical Trials

Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma

GLNE010
Start date: October 2011
Phase:
Study type: Observational

The investigators are undertaking a multi-center, 13000 subject validation study of several biomarkers for early detection of colon cancer. There are stool based biomarkers and blood based biomarkers being validated in this study. The biomarkers will be compared with colonoscopy and with FIT (fecal immunohistochemistry) tests which are the current standards for colon cancer screening. This is an NCI-early Detection Research Network funded project. The population targeted for this study are those persons undergoing colonoscopy for screening. Prior to colonoscopy or even prepping for colonoscopy, subjects will provide blood and stool samples as well as specific data regarding their GI and general medical history and concomitant medications. If subjects are interested in participating, arrangements will be made to see them. The informed consent process will take place, blood will be obtained, data will be obtained, and the stool kit described and given to the subject to take home. Stool samples will be sent back to the University of Michigan using prepaid mailing labels.

NCT ID: NCT01511458 Completed - Trisomy 21 Clinical Trials

Non-invasive Chromosomal Examination of Trisomy Study

NEXT
Start date: March 2012
Phase: N/A
Study type: Observational

The purpose of this blinded, multi-center, prospective, case-controlled study is to compare the Ariosa Harmony™ Prenatal Test for trisomy 21 detection with a standard first-trimester prenatal screening test consisting of serum screening (PAPP-A,free beta-hCG [β-hCG] or total hCG) and a nuchal translucency (NT) measurement (i.e. combined first trimester screening) in a general screened population. The performance characteristics of these two test modalities will be assessed relative to the clinical reference standard of genetic analysis of the fetus or phenotypic characterization and genetic analysis of the newborn.

NCT ID: NCT01510769 Completed - Tophaceous Gout Clinical Trials

Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat

CRYSTAL
Start date: January 2012
Phase: Phase 3
Study type: Interventional

This study will compare the serum uric acid lowering effects, clinical benefits, and safety of lesinurad in combination with febuxostat to febuxostat alone in patients with tophaceaous gout.

NCT ID: NCT01510652 Completed - Heart Failure Clinical Trials

More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions to CRT Challenges

MORE-CRT
Start date: November 2011
Phase: N/A
Study type: Interventional

This investigation is designed with the hypothesis that using a quadripolar left ventricular lead results in less interventions when dealing with high pacing thresholds and Phrenic Nerve Stimulation (PNS), both at implant and during follow-up, compared to standard bipolar left ventricular leads.

NCT ID: NCT01510340 Completed - HIV Clinical Trials

Evaluation of a Tailored Virtual Intervention to Empower Persons Living With HIV for Therapy Self-management

HIVMediconline
Start date: January 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy of an online virtual intervention in optimizing adherence to antiretroviral medication intake among Persons Living with HIV (PLHIV).

NCT ID: NCT01509885 Completed - Clinical trials for Spinal Cord Injuries

Cyproheptadine and Chlorpromazine Effects on Spasticity

Start date: July 2010
Phase: N/A
Study type: Observational

The main goal of this research is to understand the neuronal mechanisms that mediate the development of spasticity and motor dysfunction after spinal cord injury. The investigators examine how neurons and neuronal circuits in an injured nervous system adapt to produce the uncontrolled and unwanted muscle contractions that affect the majority (80%) of patients with spinal cord injury. One of the neurons that the investigators study is the motoneuron that excites the muscles of the limbs to produce movement. Previously, the investigators have shown that after spinal cord injury, the excessive and uncontrolled activity of motoneurons during muscle spasms is mediated, in large part, by the activation of calcium currents in the human motoneuron. In human patients the investigators have used recordings from single muscle fibres to estimate the contribution of these calcium currents in activating the motoneuron during muscle spasms. In this proposal, the investigators study why motoneurons recover these calcium currents and self-sustained activity after chronic spinal cord injury. Because the calcium currents require the presence of the monoamine serotonin (5HT) to activate, and this monoamine is greatly reduced after injury, the investigators examine if the calcium currents recover because the 5HT receptors become spontaneously active without the need for 5HT to bind to the receptor, which the investigators hypothesize to be one of the causes of spasticity after spinal cord injury. This research will pave the way to develop new pharmacological and rehabilitative therapies to both control spasticity after spinal cord injury and augment residual motor movements.